Skip to main content Accessibility help
×
  1. Home
  2. Books
  3. Drugs, Money, and Secret Handshakes
  • Cited by 14
      • Robin Feldman, University of California, Hastings College of the Law
      Show more authors
      • You may already have access via personal or institutional login
    • Select format
    • Publisher:
      Cambridge University Press
      Publication date:
      12 March 2019
      11 April 2019
      ISBN:
      9781108687676
      9781108482455
      DOI:
      https://doi.org/10.1017/9781108687676
      Dimensions:
      (228 x 152 mm)
      Weight & Pages:
      0.46kg, 196 Pages
      Dimensions:
      Weight & Pages:
      • Subjects:
      Area Studies, American Studies, US Law, American Government, Politics and Policy, Law, Politics and International Relations
    You may already have access via personal or institutional login
    • Selected: Digital
    Add to cart View cart Buy from Cambridge.org
    Subjects:
    Area Studies, American Studies, US Law, American Government, Politics and Policy, Law, Politics and International Relations
    Information

    Book description

    In the warped world of prescription drug pricing, generic drugs can cost more than branded ones, old drugs can be relaunched at astronomical prices, and low-cost options are shut out of the market. In Drugs, Money and Secret Handshakes, Robin Feldman shines a light into the dark corners of the pharmaceutical industry to expose a web of shadowy deals in which higher-priced drugs receive favorable treatment and patients are channeled toward the most expensive medicines. At the center of this web are the highly secretive middle players who establish coverage levels for patients and negotiate with drug companies. By offering lucrative payments to these middle players (as well as to doctors and hospitals), drug companies ensure that inexpensive drugs never gain traction. This system of perverse incentives has delivered the kind of exorbitant drug prices - and profits - that everyone loves except for those who pay the bills.

    Reviews

    'This is the book the pharmaceutical industry does not want you to read. Feldman is like a detective, teasing out drug-industry secrets and helping the reader navigate the Alice-in-Wonderland world of drug prices.'

    David Kessler - Former Commissioner, United States Food and Drug Administration

    'In this lucid and supremely upsetting book, Robin Feldman lays bare the multilayered, perverse incentives that reward pharmaceutical companies for hiking their branded drug prices into the stratosphere. Both houses of Congress should be locked in a room until they've read this book and enacted the remedies she proposes. Prosecutors should read it carefully, too.'

    Roger Parloff - Legal Journalist

    ''Everyone has a limit. Every budget has an endpoint' cannot apply to an industry that is consistently anti-competitive and monopolistic. Feldman offers potential solutions and exposes the limits inherent in each. Consumers who find this salient will be motivated to investigate further and alleviate their information gaps.'

    S. M. Mohammed Source: Choice

    Refine List

    Actions for selected content:

    Select all | Deselect all
    • View selected items
    • Export citations
    • Download PDF (zip)
    • Save to Kindle
    • Save to Dropbox
    • Save to Google Drive

    Save Search

    You can save your searches here and later view and run them again in "My saved searches".

    Please provide a title, maximum of 40 characters.
    Cancel
    ×

    Contents

    Contents
    References

    Metrics

    Altmetric attention score

    Full text views

    Total number of HTML views: 0
    Total number of PDF views: 0 *
    Loading metrics...

    Book summary page views

    Total views: 0 *
    Loading metrics...

    * Views captured on Cambridge Core between #date#. This data will be updated every 24 hours.

    Usage data cannot currently be displayed.

    Accessibility standard: Unknown

    Why this information is here

    This section outlines the accessibility features of this content - including support for screen readers, full keyboard navigation and high-contrast display options. This may not be relevant for you.

    Accessibility Information

    Accessibility compliance for the HTML of this book is currently unknown and may be updated in the future.